• Western blot analysis of lysates from A431 cells, primary antibody was diluted at 1:1000, 4°C over night

Anti-CT47A antibody (210-290 aa) (STJ190228)

SKU:
STJ190228

Current Stock:
Host: Rabbit
Applications: WB/ELISA
Reactivity: Human/Rat/Mouse
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description: Rabbit polyclonal antibody anti-Cancer/testis antigen 47A (210-290 aa) is suitable for use in Western Blot and ELISA research applications.
Clonality: Polyclonal
Conjugation: Unconjugated
Isotype: IgG
Formulation: Liquid in PBS containing 50% Glycerol and 0.02% Sodium Azide.
Purification: The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
Concentration: 1 mg/mL
Dilution Range: WB 1:500-2000
ELISA 1:5000-20000
Storage Instruction: Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles.
Gene Symbol: CT47A1.CT47A2.CT47A3.CT47A4.CT47A5.CT47A6.CT47A7.CT47A8.CT47A9.CT47A10.CT47A11.CT47A12
Gene ID: 100507170/255313/653282/728036/728042/728049/728062/728072/728075/728082/728090/728096
Uniprot ID: CT47A_HUMAN
Immunogen Region: 210-290 aa
Specificity: CT47A Polyclonal Antibody detects endogenous levels of protein.
Immunogen: Synthesized peptide derived from the human protein at the amino acid range 210-290
Protein Name Cancer/Testis Antigen 47a
Cancer/Testis Antigen 47
Ct47
Alternative Antibody Names Anti-Cancer/Testis Antigen 47a antibody
Anti-Cancer/Testis Antigen 47 antibody
Anti-Ct47 antibody
Anti-CT47A1 antibody
Anti-CT47.1.CT47A2 antibody
Anti-CT47.2.CT47A3 antibody
Anti-CT47.3.CT47A4 antibody
Anti-CT47.4.CT47A5 antibody
Anti-CT47.5.CT47A6 antibody
Anti-CT47.6.CT47A7 antibody
Anti-CT47.7.CT47A8 antibody
Anti-CT47.8.CT47A9 antibody
Anti-CT47.9.CT47A10 antibody
Anti-CT47.10.CT47A11 antibody
Anti-CT47.11.CT47A12 antibody
Anti-CT47.12 antibody

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance